Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
A randomized phase II tials to study whether it\'s benefit of adding Nimotuzumab to chemoradiation for patients with esophageal squamous cell carcinoma after radical esophagectomy who suffer with locoregional lymph nodes recurrence.
Epistemonikos ID: b55ce2afe34785df82ef5de72255a4fdda0e839b
First added on: May 06, 2024